The importance of cytogenetics and associated molecular techniques in the management of patients with leukaemia

Clinical Oncology

Volumn 10, Issue 4, 1998, Pages 255-261

  Harrison, C J ^a   Secker Walker, L M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Acute leukaemia; Cytogenetics; Diagnosis; FISH; Molecular techniques; Prognosis

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME ABERRATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENDER; GENE TECHNOLOGY; HUMAN; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031686477     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(98)80013-7     Document Type: Review

References (54)

1. Nowell PC, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science 1960;132:1497.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [Letter]. Nature 1973; 243:290-3.
3. Heim MS, Mitelman F. Cancer cytogenetics. 2nd ed. New York: Wiley-Liss, 1995.
4. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990;76:489-94.
5. Secker-Walker LM. Chromosomes and genes in acute lymphoblastic leukaemia. New York: Chapman and Hall, 1997.
6. GFCH: Groupe Francais de Cytogenetique Hematologique. Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 1993;7:10-19.
7. Secker-Walker LM, Prentice HG, Durrant J, et al. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 1997;96:601-10.
8. Annino L, Ferrari A, Cedrone M, et al. Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period. Leukemia 1994;8:664-7.
9. Bloomfield CD, Peterson LC, Yunis JJ, et al. The Philadelphia chromosome (Ph1) in adults presenting with acute leukaemia: a comparison of Ph1+ and Ph1 - patients. Br J Haematol 1977;36:347-58.
10. Tkachuk DC, Westbrook CA, Andreeff M, et al. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 1990;250:559-62.
11. Hooberman AL, Westbrook CA. Molecular methods to detect the Philadelphia chromosome. Clin Lab Med 1990;10:839-55.
12. Rowley JD. Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet 1973;16:109-12.
13. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-8.
14. Bennett JM, Catovsky D, Daniel M, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:626-9.
15. Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993;12:2715-21.
16. Sacchi N, Magnani I, Kearney L, et al. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. Cancer Genet Cytogenet 1995;79:97-103.
17. Harrison CJ, Ross F, Radford-Weiss I, et al. FISH analysis of masked t(8;21)(q22;q22) translocations. Br J Haematol 1996;93:238.
18. Rowley JD, Golomb HM, Dougherty C. 15/17 translocation: a consistent chromosomal changek in acute promyelocytic leukaemia. Lancet 1977;i:549-50.
19. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
20. Mancini M, Nanni M, Cedrone M. Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. Br J Haematol 1995;91:878-84.
21. Le Beau MM, Larson RA, Bitter MA, et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med 1983;309:630-6.
22. Liu P, Tarle SS, Hajra A, et al. Fusion between transcription factor CBF beta/PEBP beta and a myosin heavy chain in acute myeloid leukemia. Science 1993;261:1041-44.
23. Liu P, Claxton DF, Marlton P, et al. Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomemocytic leukemia. Blood 1993;82:716-21.
24. Romana SP, Le Coniat M, Berger R. t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 1994;9:186-91.
25. Romana SP, Mauchauffe M, Le Coniat M, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995;85:3662-70.
26. Romana SP, Poirel H, Leconiat M, et al. High frequently of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4263-9.
27. Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children's Cancer Group. Blood 1994;83:2274-84.
28. Bernard OA, Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 1995;13:75-85.
29. Pui C. Acute leukemias with the t(4:11)(q21;q23). Leuk Lymphoma 1992;7:173-9.
30. Harrison CJ, Cuneo A, Clark R, et al. Ten novel 11q23 chromosomal partner sites. Leukemia 1998;12.
31. le Beau M, Albain KS, Larson RA, et al. Clinical and cytogenetic correlation in 63 patients with therapy-related myelodysplastic syndrome and acute non-lymphocytic leukemia: further evidence of characteristic abnormalities of chromosomes 5 and 7. J Clin Oncol 1986;4:325-45.
32. Anastasi J, Le Beau MM, Vardiman JW, et al. Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Pathol 1990;136:131-9.
33. Menasce LP, Orphanos V, Santibanez-Koref M, et al. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Genes Chromosomes Cancer 1994;10:286-8.
34. Menasce LP, Orphanos V, Santibanez-Koref M, et al. Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia. Genes Chromosomes Cancer 1994;86:867-9.
35. Sherratt T, Morelli C, Boyle JM, Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a minimal region of deletion within a 2-megabase segment of 6q21. Chromosome Res 1997,5:118-24.
36. Kallioniemi A, Kalhoniemi O, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
37. Kallioniemi O, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chromosomes Cancer 1994;10:231-43.
38. Schrock E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
39. Speicher MR, Ballard SG, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet 1996;12:368-75.
40. Veldman T, Vignon C, Schrock E, et al. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral kayotyping. Nature Genet 1997;15:406-10.
41. Kasprzyk A, Seeker-Walker LM. Increasing sensitivity of minimal residual disease detection by interphase FISH in acute lymphoblastic leukemia with hyperdiploidy. Leukemia 1997;11:429-35.
42. Campana D, Pui C. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995;85:1416-34.
43. Lawler SD, Baker MC, Harris H, et al. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin. Br J Haematol 1984;56:431-43.
44. Anastasi J, Thangavelu M, Vardiman JW, et al. Intel-phase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood 1991;77:1087-91.
45. Secker-Walker LM. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia [10th anniversary article]. Cancer Genet Cytogenet 1990:49:1-13.
46. Seeker-Walker LM, Lawler SD, Hardisty EM. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 1978;2:1529-30.
47. Bloomfleld CD, Goldman AI, Alimena G, et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 1986;67:415-20.
48. Pui CH, Behm FG, Downing JR, et al. 11q23/MLL rearrangements confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994;12:909-15.
49. Gibbons B, MacCallum P, Watts E, et al. Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia 1991;5:738-43.
50. Berger R, Bernheim A. Cytogenetic studies on Burkitt's lymphoma-leukemia. Cancer Genet Cytogenet 1982;7:231-44.
51. Hoelzer D, Ludwig W, Eckhard E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996;87:495-508.
52. Williams DL, Look AT, Melvin SL, et al. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 1984;36:101-9.
53. Raimondi S, Roberson P, Behm FG, et al. Clinical significance of the t(1;19)(q23;p13) in childhood acute lymphoblastic leukemia [abstract]. Proc Am Assoc Cancer Res 1990;31:26.
54. Secker-Walker LM, Berger R, Fenaux P, et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992;6:363-9.